Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Cancer Causes & Control
Published in: Cancer Causes & Control 10/2018

01-10-2018 | Original paper

Intersectional nativity and racial/ethnic disparities in human papillomavirus vaccination initiation among U.S. women: a national population-based study

Authors: Madina Agénor, Sarah Abboud, Jazmine Garcia Delgadillo, Ashley E. Pérez, Sarah M. Peitzmeier, Sonya Borrero

Published in: Cancer Causes & Control | Issue 10/2018

Login to get access

Abstract

Background

Overall, foreign-born women are less likely than U.S.-born women to have initiated human papillomavirus (HPV) vaccination. However, foreign-born women are a racially/ethnically diverse population, and race/ethnicity is an independent predictor of HPV vaccination.

Methods

Using 2011–2015 National Health Interview Survey data, we used multivariable logistic regression to estimate odds ratios for foreign-born black, Latina, and Asian women compared to foreign-born white women and U.S.-born white women, adjusting for sociodemographic factors. We added socioeconomic factors followed by health care access indicators, which we conceptualized as potential mediators, to each model to assess whether they helped explain observed disparities.

Results

Foreign-born Asian ([odds ratio=] 0.43; [95% confidence interval:] 0.29–0.65) and Latina (0.46; 0.32–0.68) women had significantly lower adjusted odds of initiating HPV vaccination compared to foreign-born white women. Foreign-born white (0.64; 0.45–0.90), black (0.44; 0.29, 0.67), Latina (0.29; 0.24–0.35), and Asian (0.28; 0.21–0.38) women had significantly lower adjusted odds of HPV vaccination initiation compared to U.S.-born white women. Socioeconomic factors only explained HPV vaccination initiation disparities between foreign-born Latina women and foreign-born and U.S.-born white women. Health care access indicators modestly explained disparities between foreign-born white, black, and Latina women and U.S.-born white women only.

Conclusions

We observed pronounced HPV vaccination initiation disparities among foreign-born women in relation to race/ethnicity and between foreign-born women from minoritized racial/ethnic backgrounds and U.S.-born white women. Research on nativity disparities in HPV vaccination should take into account race/ethnicity, and vice versa. Interventions that seek to facilitate HPV vaccination among foreign-born women are needed and should address the unique needs of those from minoritized racial/ethnic backgrounds to promote cancer equity.
Literature
1.
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359–E386CrossRefPubMed
2.
3.
Seeff LC, McKenna MT (2003) Cervical cancer mortality among foreign-born women living in the United States, 1985 to 1996. Cancer Detect Prev 27:203–208CrossRefPubMed
4.
Downs LS, Smith JS, Scarinci I, Flowers L, Parham G (2008) The disparity of cervical cancer in diverse populations. Gynecol Oncol 109:S22–S30CrossRefPubMed
5.
Montealegre JR, Zhou R, Amirian ES, Follen M, Scheurer ME (2013) Nativity disparities in late-stage diagnosis and cause-specific survival among Hispanic women with invasive cervical cancer: an analysis of surveillance, epidemiology, and end results data. Cancer Causes Control 24:1985–1994CrossRefPubMedPubMedCentral
6.
Viens LJ, Henley SJ, Watson M, Markowitz LE, Thomas CC, Thompson TD, Razzaghi H, Saraiya M (2016) Human papillomavirus-associated cancers—United States, 2008–2012. MMWR 65:661–666PubMed
7.
Bates JH, Hofer BM, Parikh-Patel (2008) Cervical cancer incidence, mortality, and survival among Asian subgroups in California, 1990–2004. Cancer 113:2955–2963CrossRefPubMed
8.
Downs LS, Smith JS, Scarinci I, Flowers L, Parham G (2008) The disparity of cervical cancer in diverse populations. Gynecol Oncol 109:S22–S30CrossRefPubMed
9.
Beavis AL, Gravitt PE, Rositch AF (2017) Hysterectomy-corrected cervical cancer mortality rates reveal a larger racial disparity in the United States. Cancer 123:1044–1050CrossRefPubMed
10.
Singh GPMB (2004) Health, life expectancy, and mortality patterns among immigrant populations in the United States. Can J Public Health 95:I-14–I-21
11.
Walboomers JMM et al (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189:12–19CrossRefPubMed
12.
Markowitz LE, Liu G, Hariri S, Steinau M, Dunne EF, Unger ER (2016) Prevalence of HPV after introduction of the vaccination program in the United States. Pediatrics 137:1–9CrossRef
13.
Lu P, Rodriguez-Lainz A, O’Halloran A, Greby S, Williams WW (2014) Adult vaccination disparities among foreign-born populations in the U.S., 2012. Am J Prev Med 47:722–733CrossRefPubMedPubMedCentral
14.
De P, Budhwani (2017) Human papillomavirus (HPV) vaccine initiation in minority Americans. Public Health 144:86–91CrossRefPubMed
15.
Williams WW, Lu PJ, O’Halloran A, Bridges CB, Pilishvili T, Hales CM, Markowitz LE (2014) Noninfluenza vaccination coverage among adults—United States, 2012. MMWR 63:95–102PubMedPubMedCentral
16.
Daniel-Ulloa J, Gilbert P, Parker E (2016) Human papillomavirus vaccination in the United States: uneven uptake by gender, race/ethnicity, and sexual orientation. Am J Public Health 106:746–747CrossRefPubMedPubMedCentral
17.
Williams W, Lu P, O’Halloran A, Kim D, Grohskopf L, Pilishvili T et al (2016) Surveillance of vaccination coverage among adult populations—United States, 2014. MMWR Surveill Summ 65:1–36CrossRefPubMed
18.
Curtis C, Dorell C, Yankey D, Jeyarajah J, Chesson H, Saraiya M et al (2014) National human papillomavirus vaccination coverage among adolescents aged 13–17 years—National Immunization Survey-Teen, United States, 2011. MMWR Suppl 63:61–70PubMed
19.
Polonijo A, Carpiano R (2013) Social inequalities in adolescent human papillomavirus (HPV) vaccination: a test of fundamental cause theory. Soc Sci Med 82:115–125CrossRefPubMed
20.
21.
Gelman A, Miller E, Schwarz E, Akers A, Jeong K, Borrero S (2013) Racial disparities in human papillomavirus vaccination: does access matter? J Adolesc Health 53:756–762CrossRefPubMedPubMedCentral
22.
Collins PH, Bilge S (2016) Intersectionality. Polity Press, Cambridge
23.
Bowleg L (2012) The problem with the phrase women and minorities: intersectionality—an important theoretical framework for public health. Am J Public Health 102:1267–1273CrossRefPubMedPubMedCentral
24.
Parsons VL, Moriarity C, Jonas K, Moore TF, Davis KE, Tompkins L (2014) Design and estimation for the National Health Interview Survey, 2006–2015. Vital Health Stat 2 165:1–53
25.
Markowitz L, Dunne EF, Saraiya M, Chesson HW, Curtis CR, Gee J, Bocchini JA, Unger ER, Center for Disease Control and Prevention (CDC) (2014) Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 63:1–30PubMed
26.
Lipton BJDS (2015) ACA provisions associated with increase in percentage of young adult women initiating and completing the HPV vaccine. Health Aff 34:757–764CrossRef
27.
28.
29.
Rolnick SJ, Parker ED, Nordin JD, Hedblom BD, Wei F, Kerby T et al (2013) Self-report compared to electronic medical record across eight adult vaccines: do results vary by demographic factors? Vaccine 31:3928–3935CrossRefPubMedPubMedCentral
30.
Bruni L, Diaz M, Barrionuevo-Rosas L, Herrero R, Bray F, Bosch FX et al (2016) Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis. Lancet Glob Health 4:e453–e463CrossRefPubMed
31.
Owsianka B, Ganczak M (2015) Evaluation of human papilloma virus (HPV) vaccination strategies and vaccination coverage in adolescent girls worldwide. Przegl Epidemiol 69:53–58, 151–155
32.
Nogueira-Rodrigues A, Bukowski A, Paulino E, St Louis J, Barrichello A, Sternberg C et al (2017) An alert to Latin America: current human papillomavirus vaccination trends highlight key barriers to successful implementation. Cancer 123:2193–2199CrossRefPubMed
33.
Andrus JK, Lewis MJ, Goldie SJ, Garcia PJ, Winkler JL, Ruiz-Matus C et al (2008) Human papillomavirus vaccine policy and delivery in Latin America and the Caribbean. Vaccine 26:L80–L87CrossRefPubMed
34.
Franco EL, Tsu V, Herrero R, Lazcano-Ponce E, Hildesheim A, Munoz N et al (2008) Integration of human papillomavirus vaccination and cervical cancer screening in Latin America and the Caribbean. Vaccine 26:L88–L95CrossRefPubMed
35.
Setiawan D, Oktora MP, Hutubessy R, Riewpaiboon A, Postma MJ (2017) The health-economic studies of HPV vaccination in Southeast Asian countries: a systematic review. Expert Rev Vaccines 16:933–943CrossRefPubMed
36.
Sankaranarayanan R (2015) HPV vaccination: the most pragmatic cervical cancer primary prevention strategy. Int J Gynaecol Obstet 131:S33–S35CrossRefPubMed
37.
Perlman S, Wamai RG, Bain PA, Welty T, Welty E, Ogembo JG (2014) Knowledge and awareness of HPV vaccine and acceptability to vaccinate in sub-Saharan Africa: A systematic review. PLoS ONE 9:e90912CrossRefPubMedPubMedCentral
38.
Gee GC, Ponce N (2010) Associations between racial discrimination, limited English proficiency, and health-related quality of life among 6 Asian ethnic groups in California. Am J Public Health 100:888–895CrossRefPubMedPubMedCentral
39.
Sentell T, Braun KL (2012) Low health literacy, limited English proficiency, and health status in Asians, Latinos, and other racial/ethnic groups in California. J Health Commun 17:82–99CrossRefPubMedPubMedCentral
40.
Derose KP, Bahney BW, Lurie N, Escarce JJ (2009) Review: immigrants and health care access, quality, and cost. Med Care Res Rev 66:355–408CrossRefPubMed
41.
Okafor MT, Carter-Pokras OD, Picot SJ, Zhan M (2013) The relationship of language acculturation (English proficiency) to current self-rated health among African immigrant adults. J Immigr Minor Health 15:499–509CrossRefPubMed
42.
Lucas JW, Barr-Anderson DJ, Kington RS (2003) Health status, health insurance, and health care utilization patterns of immigrant Black men. Am J Public Health 93:1740–1747CrossRefPubMedPubMedCentral
43.
44.
Sheppard VB, Williams KP, Wang J, Shavers V, Mandelblatt JS (2014) An examination of factors associated with healthcare discrimination in Latina immigrants: the role of healthcare relationships and language. J Natl Med Assoc Summer 106:15–22CrossRef
45.
Viruell-Fuentes EA, Miranda PY, Abdulrahim S (2012) More than culture: structural racism, intersectionality theory, and immigrant health. Soc Sci Med 75:2099–2106CrossRefPubMed
46.
Perez D, Sribney WM, Rodriguez MA (2009) Perceived discrimination and self-reported quality of care among Latinos in the United States. J Gen Intern Med 24:548–554CrossRefPubMedPubMedCentral
47.
McGhee E, Harper H, Ume A, Baker M, Diarra C, Uyanne J et al (2017) Elimination of cancer health disparities through the acceleration of HPV vaccines and vaccinations: a simplified version of the President’s Cancer Panel Report on HPV vaccinations. Vaccine 8
48.
Stephens DP, Thomas TL (2013) Cultural values influencing immigrant Haitian mothers’ attitudes toward human papillomavirus vaccination for daughters. J Black Psychol 39:156–168CrossRefPubMedPubMedCentral
49.
Gerend MA, Shepherd MA, Lustria ML, Shepherd JE (2016) Predictors of provider recommendation for HPV vaccine among young adult men and women: Findings from a cross-sectional survey. Sex Transm Infect 92:104–107CrossRefPubMed
50.
Rosenthal SL, Weiss TW, Zimet GD, Ma L, Good MB, Vichnin MD (2011) Predictors of HPV vaccine uptake among women aged 19–26: importance of a physician’s recommendation. Vaccine 29:890–895CrossRefPubMed
51.
Bruno DM, Wilson TE, Gany F, Aragones A (2014) Identifying human papillomavirus vaccination practices among primary care providers of minority, low-income and immigrant patient populations. Vaccine 32:4149–4154CrossRefPubMedPubMedCentral
52.
Pierre Joseph N, Clark J, Mercilus G, Wilbur M, Figaro J, Perkins R (2014) Racial and ethnic differences in HPV knowledge, attitudes, and vaccination rates among low-income African-American, Haitian, Latina, and Caucasian young adult women. J Pediatr Adolesc Gynecol 27:83–92CrossRefPubMed
53.
54.
Epstein RM, Fiscella K, Lesser CS, Stange KC (2010) Why the Nation needs a policy push on patient-centered health care. Health Aff 29:1489–1495CrossRef
55.
Fenton AT, Elliott MN, Schwebel DC, Berkowitz Z, Liddon NC, Tortolero SR et al (2017) Unequal interactions: examining the role of patient-centered care in reducing inequitable diffusion of a medical innovation, the human papillomavirus (HPV) vaccine. Soc Sci Med 200:238–248CrossRefPubMedPubMedCentral
56.
President’s CP (2014) Accelerating HPV vaccine uptake: urgency for action to prevent cancer. A report to the President of the United States from the president’s cancer panel. National Cancer Institute, Bethesda
Metadata
Title
Intersectional nativity and racial/ethnic disparities in human papillomavirus vaccination initiation among U.S. women: a national population-based study
Authors
Madina Agénor
Sarah Abboud
Jazmine Garcia Delgadillo
Ashley E. Pérez
Sarah M. Peitzmeier
Sonya Borrero
Publication date
01-10-2018
Publisher
Springer International Publishing
Published in
Cancer Causes & Control / Issue 10/2018
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-018-1069-1

Other articles of this Issue 10/2018

Cancer Causes & Control 10/2018 Go to the issue

Review article

Indoor tanning and the risk of developing non-cutaneous cancers: a systematic review and meta-analysis

Original paper

Impact of individual and neighborhood factors on socioeconomic disparities in localized and advanced prostate cancer risk

Review article

Review of non-clinical risk models to aid prevention of breast cancer

Brief report

Temporal reliability of serum soluble and endogenous secretory receptors for advanced glycation end-products (sRAGE and esRAGE) in healthy women

Original paper

Effects of program scale-up on time to resolution for patients with abnormal screening mammography results

Brief report

Racial variation in receipt of quality radiation therapy for prostate cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits